L26/O-274 Thirteen years of chromosomal analysis of products of conception in a single center and subsequent live birth outcomes in recurrent pregnancy loss
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Hayashi und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do chromosomal abnormality rates and types in miscarriage tissue differ between women with recurrent pregnancy loss (RPL) and those with sporadic miscarriage? Summary answer Consistent with previous reports, RPL was not associated with differences in the prevalence of chromosomal abnormalities compared with sporadic miscarriage. What is known already Previous studies have consistently shown that the prevalence and spectrum of chromosomal abnormalities in miscarriage tissue do not differ significantly according to the number of prior pregnancy losses. Existing literature indicates that 60–80% of women with RPL eventually achieve a live birth, even without specific therapeutic intervention. Study design, size, duration We retrospectively analyzed 1,490 cases of G-banding chromosomal analysis of products of conception performed at our institution between January 2011 and December 2023. Participants/materials, setting, methods This study was conducted at a single specialized fertility center, where most pregnancies resulted from assisted reproductive technology (ART). Chromosomal analysis of products of conception was evaluated according to the number of prior miscarriages (one, two, and three or more). Subsequent pregnancy outcomes were further assessed in women with three or more pregnancy losses. Main results and the role of chance Among 1,490 pregnancies, conception methods included assisted reproductive technology (ART) in 1,133 cases, timed intercourse in 280 cases, and intrauterine insemination in 77 cases. The mean age at the time of genetic testing was 37.2 ± 4.3 years. Chromosomal analysis of products of conception was unsuccessful in 28 cases. Of the remaining samples, 447 showed normal karyotypes or normal variants, while 958 were abnormal, including aneuploidy (n = 881), polyploidy (n = 36), structural abnormalities (n = 36), combined aneuploidy and structural abnormalities (n = 5), and mosaicism (n = 57). The prevalence of chromosomal abnormalities did not differ significantly according to the number of prior pregnancy losses, with abnormality rates of 69.6%, 66.3%, and 73.2% in women with a first, second, and third or more miscarriage, respectively. Among 254 women with three or more pregnancy losses, the subsequent live birth rate after miscarriage was 52.0% (132/254); of these, 104 achieved live birth with the same treatment as at miscarriage, while 28 required additional interventions. No statistically significant differences were observed between groups, suggesting that the observed findings were unlikely to be attributable to chance alone. Limitations, reasons for caution This retrospective single-center study, conducted in a fertility center with mostly ART pregnancies, may have limited generalizability, and follow-up was incomplete for patients who transferred to other clinics. Conventional G-banding may underestimate submicroscopic abnormalities and is subject to culture failure and potential mosaicism-related artifacts. Wider implications of the findings These findings support the continued use of products-of-conception chromosomal analysis in RPL for etiologic classification and prognostic counseling, and may help reassure couples that a subsequent live birth is achievable even after multiple miscarriages. Trial registration number No
Zitieren
APA
Hayashi, N., Nakahara, E., Enatsu, N., Enatsu, Y., Mizusawa, Y., Shibahara, H., Okamoto, E., Kokeguchi, S., & Shiotani, M. (2026). L26/O-274 Thirteen years of chromosomal analysis of products of conception in a single center and subsequent live birth outcomes in recurrent pregnancy loss. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.272
Vancouver
Hayashi N, Nakahara E, Enatsu N, Enatsu Y, Mizusawa Y, Shibahara H, et al. L26/O-274 Thirteen years of chromosomal analysis of products of conception in a single center and subsequent live birth outcomes in recurrent pregnancy loss. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.272
BibTeX
@article{Hayashi2026,
author = {Hayashi, N. and Nakahara, E. and Enatsu, N. and Enatsu, Y. and Mizusawa, Y. and Shibahara, H. and Okamoto, E. and Kokeguchi, S. and Shiotani, M.},
title = {L26/O-274 Thirteen years of chromosomal analysis of products of conception in a single center and subsequent live birth outcomes in recurrent pregnancy loss},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.272}
}
EUVIMED